CurrentEndo
Get Weekly

Topic · page 55 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 2,161–2,200 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Res Clin Pract

    Midline venous catheter: New insights for its use in hospitalized patients with diabetes

    Cohort study

  2. J Clin Endocrinol Metab

    The Association Between Serum Polychlorinated Biphenyls and Incident Cardiovascular Disease Among Type 2 Diabetes

    Cohort study

  3. Diabetes Obes Metab

    Association of changes in the type 2 diabetes and MASLD /related SLD status with risk of developing cardiovascular disease

    Cohort study

  4. Diabet Med

    Differential effect of nonpharmacological interventions according to prediabetes phenotype: Systematic review and meta‐analysis of randomized clinical trials

    Meta-analysis

  5. Diabetes Care

    Financial Incentives, Income Supplementation, Cash Transfer, and Universal Basic Income Interventions in Diabetes: Understanding Differences and Effectiveness: A Scoping Review

    Research article

  6. Diabetologia

    Monounsaturated fatty acids from plant or animal sources and risk of type 2 diabetes in three large prospective cohorts of men and women

    Cohort study

  7. J Diabetes Sci Technol

    Effectiveness of Mobile Health Applications for Cardiometabolic Risk Reduction in Urban and Rural India: A Pilot, Randomized Controlled Study

    Randomized controlled trial

  8. Lancet Diabetes Endocrinol

    Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial

    Secondary analysis

  9. Diabetes Res Clin Pract

    Call to action for clinicians in the South-East Asian regions on primary prevention of diabetes in people with prediabetes- A consensus statement

    Guideline or statement

  10. Cardiovasc Diabetol

    Echocardiographic phenotypes of diabetic myocardial disorder: evolution over 15 months follow-up in the ARISE-HF trial

    Secondary analysis

  11. Cardiovasc Diabetol

    Improving 10-year cardiovascular risk prediction in patients with type 2 diabetes with metabolomics

    Diagnostic or prognostic study

  12. Cardiovasc Diabetol

    Association between estimated glucose disposal rate and cardiovascular diseases in patients with diabetes or prediabetes: a cross-sectional study

    Cross-sectional study

  13. Diabetes Obes Metab

    Effect of insulin sensitivity, insulin secretion, and beta cell function on the remission of type 2 diabetes: A post hoc analysis of the IDEATE trial

    Secondary analysis

  14. Diabetes Obes Metab

    Effects of the SGLT2 inhibitor ipragliflozin and metformin on hepatic steatosis and liver fibrosis: Sub‐analysis of a randomized controlled study

    Secondary analysis

  15. Diabetes Obes Metab

    Risk of insulin initiation with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes mellitus: A real‐world claims database study in Japan

    Cohort study

  16. Diabet Med

    Protocol for a 1‐year randomised, controlled, parallel group, open‐label trial on the effects and feasibility of time‐restricted eating in individuals with type 2 diabetes‐ The REStricted Eating Time in the treatment of type 2 diabetes (RESET2) trial

    Trial design

  17. Diabetes Obes Metab

    Real‐world retrospective study in elderly patients aged 65 years and older with type 2 diabetes mellitus treated with daily oral semaglutide ( SEMA ‐elderly)

    Cohort study

  18. Diabetes Res Clin Pract

    Burden of vascular risk factors by age, sex, ethnicity and deprivation in young adults with and without newly diagnosed type 2 diabetes

    Cohort study

  19. J Clin Endocrinol Metab

    Effect of Hypoglycemia on QT Interval in Individuals With and Without Type 2 Diabetes: A Randomized Crossover Trial

    Randomized controlled trial

  20. J Diabetes Sci Technol

    Advancing Monogenic Diabetes Research and Clinical Care by Creating a Data Commons: The Precision Diabetes Consortium (PREDICT)

    Research article

  21. Diabetes Obes Metab

    Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial

    Meta-analysis

  22. Diabetes Care

    Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and the Prevention of Cirrhosis Among Patients With Type 2 Diabetes

    Cohort study

  23. Cardiovasc Diabetol

    Predicting 28-day all-cause mortality in patients admitted to intensive care units with pre-existing chronic heart failure using the stress hyperglycemia ratio: a machine learning-driven retrospective cohort analysis

    Cohort study

  24. Cardiovasc Diabetol

    Impact of remnant cholesterol on short-term and long-term prognosis in patients with prediabetes or diabetes undergoing coronary artery bypass grafting: a large-scale cohort study

    Cohort study

  25. Diabetologia

    Sugar-sweetened or artificially sweetened beverage consumption, physical activity and risk of type 2 diabetes in US adults

    Cohort study

  26. Diabetes Obes Metab

    Long‐term health benefit and economic return of time in range ( TIR ) improvement in individuals with type 2 diabetes

    Research article

  27. Thyroid

    Glucagon-Like Peptide 1 Receptor Agonists and Risk of Thyroid Cancer: An International Multisite Cohort Study

    Meta-analysis

  28. Diabetes Obes Metab

    Association of Metformin use with risk of dementia in patients with type 2 diabetes: A systematic review and meta‐analysis

    Meta-analysis

  29. Diabetes Obes Metab

    Impact of TCF7L2 rs7903146 on clinical presentation and risk of complications in patients with type 2 diabetes

    Cohort study

  30. Diabetes Obes Metab

    A preliminary randomized trial of a brief dissonance‐based type 2 diabetes prevention programme for adults with pre‐diabetes

    Randomized controlled trial

  31. Diabetes Metab

    New users of sodium-glucose cotransporter 2 inhibitors are at low risk of incident pancreatic cancer: A nationwide population-based cohort study

    Cohort study

  32. Diabetes Obes Metab

    Socioeconomic and mental health inequalities in global burden of type 2 diabetes: Evidence from the Global Burden of Disease Study 2021

    Cross-sectional study

  33. Diabetes Obes Metab

    Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis

    Secondary analysis

  34. Diabetes Obes Metab

    Treatment outcomes with oral anti‐hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c diabetes): A population‐based cohort study

    Cohort study

  35. Diabetes Care

    Plasma Lipid Metabolites, Clinical Glycemic Predictors, and Incident Type 2 Diabetes

    Cohort study

  36. Diabetes Care

    Diabetes, Subclinical Myocardial Injury or Stress, and Risk of Heart Failure Subtypes: The Jackson Heart Study

    Cohort study

  37. Cardiovasc Diabetol

    The additive effect of the stress hyperglycemia ratio on type 2 diabetes: a population-based cohort study

    Cohort study

  38. Nat Med

    Burdens of type 2 diabetes and cardiovascular disease attributable to sugar-sweetened beverages in 184 countries

    Research article

  39. Diabetes Obes Metab

    Effectiveness and safety of iGlarLixi in people with type 2 diabetes not at target on basal insulin and oral antidiabetic therapy in a prospective observational trial

    Cohort study

  40. Diabetes Technol Ther

    A Randomized Controlled Trial Using Continuous Glucose Monitoring to Guide Food Choices and Diabetes Self-Care in People with Type 2 Diabetes not Taking Insulin

    Randomized controlled trial

All 4,758 Briefs in ExploreShowing Briefs 2,161–2,200 of 4,758, newest first